Clinical Trials
2
Active:0
Completed:0
Trial Phases
2 Phases
Phase 2:1
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (50.0%)Phase 4
1 (50.0%)Safety Study for Short-course Accelerated, Hypofractionated Partial Breast Radiotherapy (APBI) in Women With Early Stage Breast Cancer Using the Contura MLB
Phase 2
Terminated
- Conditions
- Breast Cancer
- First Posted Date
- 2010-02-22
- Last Posted Date
- 2013-06-17
- Lead Sponsor
- SenoRx, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT01072838
- Locations
- 🇺🇸
William Beaumont Hospital, Royal Oak, Michigan, United States
🇺🇸Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
🇺🇸Virginia Commonwealth University, Richmond, Virginia, United States
Using the Conture® Multi-Lumen Balloon to Deliver Accelerated Partial Breast Brachytherapy
Phase 4
Terminated
- Conditions
- Breast Cancer
- First Posted Date
- 2008-06-17
- Last Posted Date
- 2013-06-17
- Lead Sponsor
- SenoRx, Inc.
- Target Recruit Count
- 342
- Registration Number
- NCT00699101
- Locations
- 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States
News
No news found